Cover Image
市場調查報告書

MediPoint:腎交感神經去除術 - 全球市場的分析與預測

MediPoint: Renal Denervation - Global Analysis and Market Forecasts

出版商 GlobalData 商品編碼 290474
出版日期 內容資訊 英文 92 Pages
訂單完成後即時交付
價格
Back to Top
MediPoint:腎交感神經去除術 - 全球市場的分析與預測 MediPoint: Renal Denervation - Global Analysis and Market Forecasts
出版日期: 2016年04月01日 內容資訊: 英文 92 Pages
簡介

本報告提供全球腎交感神經去除術市場相關調查分析,提供疾病概要,上市產品,未滿足需求,開發中產品相關驗證,臨床試驗分析,提供產業概要,再加上主要企業簡介,各國預測與預測等,為您概述為以下內容。

第1章 目錄

第2章 簡介

第3章 疾病概要

  • 解剖學·生理學
  • 病理學
  • 病因
  • 臨床表現
  • 流行病學
  • 經濟影響

第4章 上市產品

  • 概要
  • 市場佔有率
  • AllegraRenal Denervation System (Terumo Corporation/AngioCare)
  • EnligHTNRenal Denervation System (St. Jude Medical)
  • OneShotRenal Denervation System (Covidien)
  • ParadiseRenal Denervation System (ReCor Medical)
  • SymplicityRenal Denervation System (Medtronic)
  • VessixRenal Denervation System (Boston Scientific Corporation)

第5章 未滿足需求

  • 概要

第6章 開發中產品

  • 概要
  • Beta-Cath System (Best Medical International)
  • Bullfrog MicroFusion Catheter (Mercator MedSystems)
  • Chemicaldenabeshonshisutemu (Kipprokration Hospital)
  • Cryoablation System (Cryomend)
  • Kona Surround Sound System (Kona Medical)
  • Magnetic Nanoparticles (ApexNano)
  • PerivascularRenal Denervation System (Ablative Solutions)
  • Sound 360 UltrasonicRenal Denervation System (Sound Interventions)
  • Symple Surgical System (Symple Surgical)
  • Tivus System (Cardiosonic)
  • Celsius ThermoCool System (Cordis/Johnson & Johnson)
  • Northwind Medical System (Northwind Medical)
  • Verve Medical System (Verve Medical)

第7章 臨床試驗分析

  • 概要
  • 臨床試驗的時間軸
  • 臨床試驗的結果
  • 應該關注的實驗分析

第8章 產業概要

  • 治療趨勢
  • 打入市場
  • 給付趨勢
  • 法規的問題/回收
  • 附加的功效
  • M&A/夥伴關係

第9章 現在/未來的主要企業

  • 企業策略趨勢
  • 企業簡介
    • Ablative Solutions
    • ApexNano
    • Best Medical International
    • Boston Scientific Corporation
    • Cardiosonic
    • Covidien
    • Cordis Corporation and Johnson & Johnson
    • Cryomend
    • Kona Medical
    • Medtronic
    • Mercator MedSystems
    • Northwind Medical
    • ReCor Medical
    • Sound Interventions
    • St. Jude Medical
    • Symple Surgical
    • Terumo Corporation
    • Verve Medical
    • 其他的企業

第10章 推動市場要素和機會

  • 推動市場要素
  • 市場機會
  • 市場威脅

第11章 各國預測與預測

  • 概要
  • 美國
  • 法國
  • 德國
  • 義大利
  • 西班牙
  • 英國
  • 日本
  • 巴西
  • 印度
  • 中國

第12章 附錄

圖表

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GDME0226MAR

Renal denervation catheters are categorized into the following: radiofrequency (RF) catheters, ultrasound catheters, and micro-injection catheters.

Growth in the renal denervation market will be driven primarily by a need for a new intervention to treat resistant hypertension.

This technology has the potential to revolutionize the cardiac field, providing a minimally invasive solution where none currently exist.

The global market for renal denervation devices is dominated by Medtronic, St. Jude Medical, and Boston Scientific.

Other key players include Cordis, ReCor Medical, and Terumo.

Highlights

Key Questions Answered

  • What is the current and future renal denervation market outlook in the developed and emerging markets? What trends and events are affecting the global market?
  • Which are the key, high growth markets that device manufacturers should expand into? Which markets are growing the fastest, and what are the top-selling products?
  • What are the unmet needs with the current generation of devices ? How will emerging technologies such as the next generation radiofrequency and ultrasound catheters and new micro-injection catheters fulfill these unmet needs?
  • How will current and future clinical trials affect the market? When are new devices expected to commercialize?
  • What are the challenges and complications that have hindered widespread adoption?
  • With developing the next-generation of devices, what aspects of the technology are device manufacturers focused on optimizing? How will new entrants impact the global peripheral vascular interventions market?

Scope

  • Competitive assessment: Currently marketed renal denervation products and evolving competitive landscape
  • In-depth analysis of unmet needs and adoption trends of different renal denervation devices
  • Insightful review of the key industry drivers, opportunities, restraints and challenges. Each trend is independently researched to provide qualitative analysis of its implications
  • Pipeline analysis: Emerging products and technologies.
  • Annualized total renal denervation diagnostics market revenue by segment and market outlooks by country from 2012-2022.
  • Other key topics covered include strategic competitive assessment, market characterization, identification of unmet needs, market dynamics, and implications of the emerging technologies on the market.

Reasons to buy

The report will enable you to -

  • Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline.
  • Develop business strategies by understanding the trends shaping and driving the global renal denervation market.
  • Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the global renal denervation market in the future.
  • Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors.
  • Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
  • Track device sales in the global and country-specific renal denervation market from 2012-2022.
  • Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.

Table of Contents

1. Table of Contents

  • 1.1. List of Tables
  • 1.2. List of Figures

2. Introduction

  • 2.1. Catalyst
  • 2.2. Related Reports

3. Market Access

  • 3.1. The Symplicity HTN-3 Trial
  • 3.2. Reimbursement
    • 3.2.1. Europe
    • 3.2.2. Russia
    • 3.2.3. Australia
  • 3.3. M&A/Key Partnerships
    • 3.3.1. The Cardinal Health Acquisition of Cordis
    • 3.3.2. The Boston Scientific Acquisition of Vessix Vascular
    • 3.3.3. The Medtronic Acquisition of Ardian

4. Unmet Needs

  • 4.1. Overview
  • 4.2. Nerve Regeneration
  • 4.3. Ambulatory Blood Pressure Readings
  • 4.4. Expanded Indications for the Use of Renal Denervation
  • 4.5. Intervention to Monitor Treatment Progress
  • 4.6. Long-Term Effects

5. Competitive Assessment

  • 5.1. Company Share Analysis
  • 5.2. Major Players
    • 5.2.1. Ablative Solutions
    • 5.2.2. Boston Scientific
    • 5.2.3. CardioSonic
    • 5.2.4. Cordis Corporation
    • 5.2.5. Kona Medical
    • 5.2.6. Medtronic
    • 5.2.7. ReCor Medical
    • 5.2.8. Renal Dynamics
    • 5.2.9. St. Jude Medical
    • 5.2.10. Terumo
  • 5.3. Emerging Players

6. Market Outlooks

  • 6.1. Procedure Trends
  • 6.2. Market Drivers and Barriers
    • 6.2.1. Market Driver 1: Large Disease Prevalence
    • 6.2.2. Market Driver 2: Expanding Indications
    • 6.2.3. Market Barrier 1: Dependency on Clinical Trials
    • 6.2.4. Market Barrier 2: Reimbursement
    • 6.2.5. Market Barrier 3: Development of Competing Technology
  • 6.3. Market Outlooks by Segment
    • 6.3.1. Radiofrequency Catheters
    • 6.3.2. Ultrasound Catheters
    • 6.3.3. Micro-infusion Catheters
  • 6.4. Market Outlooks by Geography
    • 6.4.1. North America
    • 6.4.2. Europe
    • 6.4.3. Asia-Pacific
    • 6.4.4. South America

7. Appendix

  • 7.1. Bibliography
  • 7.2. Abbreviations
  • 7.3. Methodology
    • 7.3.1. Overview
    • 7.3.2. Coverage
  • 7.4. Forecasting Methodology
    • 7.4.1. Overview
    • 7.4.2. Patient Population
    • 7.4.3. Procedure Volume by Type of Disease
    • 7.4.4. Procedure Volume by Type of Device
    • 7.4.5. Average Selling Price
  • 7.5. Primary Research Efforts
  • 7.6. About the Authors
    • 7.6.1. Brigitte Babin, MSc, Analyst, Medical Devices
    • 7.6.2. Linda Tian, MSc, Managing Analyst, Medical Devices
    • 7.6.3. Tyler Fletcher, BSc, Global Head of Medical Devices
  • 7.7. About GlobalData
  • 7.8. Disclaimer

List of Tables

  • Table 1: Mergers and Acquisitions/Key Partnership
  • Table 2: Clinical Trials Currently Underway Assessing Other Indications for Renal Denervation
  • Table 3: Key Clinical Trials Assessing Other Indications for Renal Denervation
  • Table 4: Company Profile - Ablative Solutions Inc.
  • Table 5: Ablative Solutions - SWOT Analysis, 2016
  • Table 6: Company Profile - Boston Scientific
  • Table 7: Boston Scientific - SWOT Analysis, 2016
  • Table 8: Product Profile - Vessix Renal Denervation System
  • Table 9: Company Profile - CardioSonic Inc.
  • Table 10: CardioSonic. - SWOT Analysis, 2016
  • Table 11: Product Profile - TIVUS Renal Denervation System
  • Table 12: Company Profile - Cordis Corporation
  • Table 13: Cordis - SWOT Analysis, 2016
  • Table 14: Product Profile - RENLANE Renal Denervation System
  • Table 15: Company Profile - Kona Medical Inc.
  • Table 16: Kona Medical Inc. - SWOT Analysis, 2016
  • Table 17: Company Profile - Medtronic
  • Table 18: Medtronic - SWOT Analysis, 2016
  • Table 19: Product Profile - Symplicity Flex Renal Denervation Catheter
  • Table 20: Product Profile - Symplicity Spyral Renal Denervation Catheter
  • Table 21: Company Profile - ReCor Medical Inc.
  • Table 22: ReCor Medical, Inc. - SWOT Analysis, 2015
  • Table 23: Product Profile - Paradise Renal Denervation System
  • Table 24: Company Profile - Renal Dynamics
  • Table 25: Renal Dynamics - SWOT Analysis, 2015
  • Table 26: Product Profile - ReDy Renal Denervation System
  • Table 27: Company Profile - St. Jude Medical
  • Table 28: St. Jude Medical - SWOT Analysis, 2016
  • Table 29: Product Profile - EnligHTN Renal Denervation System
  • Table 30: Company Profile - Terumo
  • Table 31: Terumo - SWOT Analysis, 2016
  • Table 32: Product Profile - Iberis Rrenal Denervation System
  • Table 33: Summary of Emerging Players and Associated Renal Denervation Technologies
  • Table 34: Global Radiofrequency Catheter - Renal Denervation Sales ($m) Forecast, 2012-2022
  • Table 35: Global Ultrasound Catheter - Renal Denervation Sales ($m) Forecast, 2012-2022
  • Table 36: Micro-Infusion Catheter clinical trials
  • Table 37: Canada Renal Denervation Sales ($m) Forecast, 2012-2022
  • Table 38: Mexico Renal Denervation Sales ($m) Forecast, 2012-2022
  • Table 39: US Renal Denervation Sales ($m) Forecast, 2012-2022
  • Table 40: France Renal Denervation Sales ($m) Forecast, 2012-2022
  • Table 41: Germany Renal Denervation Sales ($m) Forecast, 2012-2022
  • Table 42: Italy Renal Denervation Sales ($m) Forecast, 2012-2022
  • Table 43: Russia Renal Denervation Sales ($m) Forecast, 2012-2022
  • Table 44: Spain Renal Denervation Sales ($m) Forecast, 2012-2022
  • Table 45: UK Renal Denervation Sales ($m) Forecast, 2012-2022
  • Table 46: Australia Renal Denervation Sales ($m) Forecast, 2012-2022
  • Table 47: China Renal Denervation Sales ($m) Forecast, 2012-2022
  • Table 48: India Renal Denervation Sales ($m) Forecast, 2012-2022
  • Table 49: Japan Renal Denervation Sales ($m) Forecast, 2012-2022
  • Table 50: South Korea Renal Denervation Sales ($m) Forecast, 2012-2022
  • Table 51: Brazil Renal Denervation Sales ($m) Forecast, 2012-2022

List of Figures

  • Figure 1: Steps Required Prior to Treatment with Renal Denervation
  • Figure 2: Global Company Share Analysis - Renal Denervation
  • Figure 3: Vessix V2 Renal Denervation Catheter
  • Figure 4: RENLANE Renal Denervation Catheter
  • Figure 5: Surround Sound Renal Denervation System
  • Figure 6: Symplicity Spyral Renal Denervation Catheter
  • Figure 7: Paradise Ultrasound Renal Denervation Catheter
  • Figure 8: EnligHTN Renal Denervation System
  • Figure 9: Composition of Global Renal Denervation by Procedure Volumes, 2015 and 2022
  • Figure 10: Global Renal Denervation Market Value ($m) - High-, Mid-, and Low-Level Predictive Adoption Models, 2012-2022
  • Figure 11: Global Renal Denervation Procedure Volume Forecast, 2012-2022
  • Figure 12: Comparison of Major Geography Segments, 2012-2022
  • Figure 13: North American Renal Denervation Procedure Volume, 2012-2022
  • Figure 14: Canada Renal Denervation Sales ($m) Forecast, 2012-2022
  • Figure 15: Mexico Renal Denervation Sales ($m) Forecast, 2012-2022
  • Figure 16: US Renal Denervation Sales ($m) Forecast, 2012-2022
  • Figure 17: European Renal Denervation Procedure Volume, 2012-2022
  • Figure 18: France Renal Denervation Sales ($m) Forecast, 2012-2022
  • Figure 19: Germany Renal Denervation Sales ($m) Forecast, 2012-2022
  • Figure 20: Italy Renal Denervation Sales ($m) Forecast, 2012-2022
  • Figure 21: Russia Renal Denervation Sales ($m) Forecast, 2012-2022
  • Figure 22: Spain Renal Denervation Sales ($m) Forecast, 2012-2022
  • Figure 23: UK Renal Denervation Sales ($m) Forecast, 2012-2022
  • Figure 24: APAC Renal Denervation Market Value, 2012-2022
  • Figure 25: Australia Renal Denervation Sales ($m) Forecast, 2012-2022
  • Figure 26: China Renal Denervation Sales ($m) Forecast, 2012-2022
  • Figure 27: India Renal Denervation Sales ($m) Forecast, 2012-2022
  • Figure 28: Japan Renal Denervation Sales ($m) Forecast, 2012-2022
  • Figure 29: South Korea Renal Denervation Sales ($m) Forecast, 2012-2022
  • Figure 30: Brazil Renal Denervation Sales ($m) Forecast, 2012-2022
  • Figure 31: Survey Breakdown by Profession
Back to Top